Schedule 13G ownership disclosure
ARCA BIOPHARMA INC
Security class unavailable · CUSIP: 00211Y506
Event date: 2020-06-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 174,000
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-20-005573
- Form type
- SC 13G
- Filer
- Oruka Therapeutics, Inc.
- CIK
- CIK 907654
- Filed
- Jun 10, 2020
- Reporting period
- Jun 01, 2020
- Description
- Schedule 13G beneficial ownership